In the last six months, telehealth has been the quintessential overnight success story (that was really about 30 years in the making). I hate to say it, but these really are unprecedented times. There’s a new normal emerging in healthcare, and the industry is being tasked with managing learning curves and growing pains, all in real-time. The industry will undoubtedly continue to advance and expand, and at Zipnosis we’ll adapt along with it. But let me be clear, some things will never change. At Zipnosis, we aren’t—and never will be—your typical telehealth model. We’ll always believe in creating healthcare that works, and we won’t stop until we do.
Related Insights.
Regulatory Roundup – July 2022
Interested in the latest legislation affecting the telehealth industry? You’ve come to the right place! Let's take a look at how regulations changed in July. Federal US House Bill 4040 — Connecting Rural Telehealth to the Future Act — Passed Introduced on June 22,...
Asynchronous Telemedicine Protocols for Travel-Related Illnesses
With vacation season in full swing, many people ask how they can prevent unforeseen illnesses from disrupting their travel plans. Zipnosis offers a suite of travel-related protocols that allows health systems to efficiently provide care to patients preparing for...
Paxlovid: Expanding prescribing authority isn’t enough to increase access
This month, the FDA authorized state-licensed pharmacists to prescribe Paxlovid to eligible patients with COVID-19. According to the director for the FDA’s Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., this new limited authorization should allow...
Put yourself at the forefront of a revolution.